Literature DB >> 27909839

Biventricular support using a centrifugal pump in a 6 year old with fulminant myocarditis.

Hiromu Kehara1, Tamaki Takano2, Takamitsu Terasaki3, Kenji Okada4.   

Abstract

We experienced a case of ventricular assist with both a pulsatile-flow and a continuous-flow pump in a pediatric patient, and herein report the clinical course and characteristics of the pumps. A 6-year-old female was diagnosed with fulminant myocarditis and transferred to our hospital for mechanical support. After 12 days of extracorporeal membrane oxygenation, we implanted a left ventricular assist device (LVAD) and a right ventricular assist device (RVAD) using centrifugal Gyro pumps with a membrane oxygenator in a paracorporeal fashion. The membrane oxygenator was removed on postoperative day (POD) 4, and the patient was weaned from the respirator on POD 6. The LVAD was exchanged on POD 13 and 17, and the RVAD was exchanged on POD 14 because of thrombus formation inside the pumps. The RVAD was removed on POD 25. On POD 32, the patient experienced cerebral infarction and the centrifugal Gyro pump was switched to an extracorporeal pulsatile pump. No thromboembolic event occurred after pump conversion, although continuous administration of vasodilators was required to avoid hypertension. She underwent successfully heart transplantation in the USA after 8 months of ventricular support. A centrifugal pump is considered useful for pediatric patients, as pump flow and blood pressure can be relatively easily controlled in the postoperative acute phase compared with the pulsatile pump. However, special care should be taken to monitor for thrombus formation when support length becomes longer than 13 days, and a switch to a pulsatile pump should be considered once the hemodynamic status stabilizes.

Entities:  

Keywords:  Biventricular assist device; Centrifugal pump; Fulminant myocarditis; Heart transplantation; Pediatric

Mesh:

Year:  2016        PMID: 27909839     DOI: 10.1007/s10047-016-0939-0

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  5 in total

1.  Development of an antithrombogenic and antitraumatic blood pump: the Gyro C1E3.

Authors:  T Takano; K Nakata; M Yoshikawa; T Maeda; J Glueck; A Fujisawa; K Makinouchi; M Yokokawa; S Murabayashi; Y Nosé
Journal:  ASAIO J       Date:  2000 Jan-Feb       Impact factor: 2.872

2.  Thrombus formation patterns in the HeartMate II ventricular assist device: clinical observations can be predicted by numerical simulations.

Authors:  Wei-Che Chiu; Marvin J Slepian; Danny Bluestein
Journal:  ASAIO J       Date:  2014 Mar-Apr       Impact factor: 2.872

3.  MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis.

Authors:  J Martin; K Sarai; M Schindler; A van de Loo; M Yoshitake; F Beyersdorf
Journal:  Ann Thorac Surg       Date:  1997-04       Impact factor: 4.330

4.  Five-week use of a monopivot centrifugal blood pump as a right ventricular assist device in severe dilated cardiomyopathy.

Authors:  Takamichi Inoue; Tadashi Kitamura; Shinzo Torii; Naoji Hanayama; Norihiko Oka; Keiichi Itatani; Takahiro Tomoyasu; Yusuke Irisawa; Miyuki Shibata; Hidenori Hayashi; Minoru Ono; Kagami Miyaji
Journal:  J Artif Organs       Date:  2013-11-28       Impact factor: 1.731

5.  Development of a compact wearable pneumatic drive unit for a ventricular assist device.

Authors:  Akihiko Homma; Yoshiyuki Taenaka; Eisuke Tatsumi; Eiki Akagawa; Hwansung Lee; Tomohiro Nishinaka; Yoshiaki Takewa; Toshihide Mizuno; Tomonori Tsukiya; Yukihide Kakuta; Nobumasa Katagiri; Isao Shimosaki; Shigeru Hamada; Hiroshi Mukaibayashi; Wataru Iwaoka
Journal:  J Artif Organs       Date:  2008-12-17       Impact factor: 1.731

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.